Par Pharmaceutical Companies, Inc.
Par Pharmaceutical Companies, Inc. (Par Pharmaceutical) is a publicly traded pharmaceutical company. It is engaged in the research, development, manufacturing and marketing of generic drugs and branded drugs for specialty in the US markets. It consists of nearly 50 drugs with associated Abbreviated New Drug Application and approximately 175 SKUs. The company markets oral suspension products and products in the semi-solid form of a cream. It operates its business through two divisions Par Pharmaceutical, a generic drug division and Strativa Pharmaceuticals, a proprietary products. Its generic drugs consists of numerous products across all therapeutic areas. Its operating locations include Spring Valley, Suffern and Hauppauge. Par Pharmaceutical is headquartered at Woodcliff Lake in New Jersey, the US.
Company Index Score
| Current Index Score | Historical Index Score |
![]() |
|
| |
Latest tweets
More from New Statesman
- Online writers:
- Steven Baxter
- Rowenna Davis
- David Allen Green
- Mehdi Hasan
- Nelson Jones
- Gavin Kelly
- Helen Lewis
- Laurie Penny
- The V Spot
- Alex Hern
- Martha Gill
- Alan White
- Samira Shackle
- Alex Andreou
- Nicky Woolf in America
- Bim Adewunmi
- Glosswitch
- Kate Mossman on pop
- Ryan Gilbey on Film
- Martin Robbins
- Rafael Behr
- Eleanor Margolis
- Tools and services:
- Polls
- Predictions
- Archive
- Magazine
- PDF edition
- RSS feeds
- Advertising
- Subscribe
- Special supplements
- Stockists

